Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma Receiving Pemetrexed/Platinum Protocol

NCT02761863 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT02761863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02761863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma Receiving Pemetrexed/Platinum Protocol
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Unknown status
Start date
July 30, 2019
Completion date
July 30, 2021
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural mesothelioma